Recombinant Human Frizzled-5 Fc Chimera (CHO-expressed), CF
R&D Systems, part of Bio-Techne | Catalog # 1617-FZC
Key Product Details
Source
CHO
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Chinese Hamster Ovary cell line, CHO-derived human Frizzled-5 protein
Human Frizzled-5 (Ala27-Trp238) Accession # NP_003459 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Ala27 and Ser28
Predicted Molecular Mass
50.1 kDa (monomer)
SDS-PAGE
60-68 kDa, reducing conditons
Activity
Measured by its binding ability in a functional ELISA.
In a 100 µL reaction mixture containing biotinylated recombinant mouse Wnt-5a at 100 ng/mL and Recombinant Human Frizzled‑5 Fc Chimera dilutions, the concentration of Recombinant Human Frizzled‑5 Fc Chimera that produces 50% of the maximal binding response is found to be approximately 5‑20 ng/mL.
Optimal concentrations should be determined by each laboratory for each application.
In a 100 µL reaction mixture containing biotinylated recombinant mouse Wnt-5a at 100 ng/mL and Recombinant Human Frizzled‑5 Fc Chimera dilutions, the concentration of Recombinant Human Frizzled‑5 Fc Chimera that produces 50% of the maximal binding response is found to be approximately 5‑20 ng/mL.
Optimal concentrations should be determined by each laboratory for each application.
Formulation, Preparation and Storage
1617-FZC
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 200 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Frizzled-5
References
- Schulte, G. (2015) Eur. J. Pharmacol. 763:191.
- Saitoh T. et al. (2001) Int. J. Oncol. 19:105.
- Liu, C. et al. (2008) J. Neurosci. 28:5641.
- Katoh, Y. and M. Katoh (2007) Int. J. Oncol. 30:751.
- Ishikawa, T. et al. (2001) Development 128:25.
- Burns, C.J. et al. (2008) Dev. Dyn. 237:1614.
- Periera, C. et al. (2008) Arterioscler. Thromb. Vasc. Biol. 28:504.
- Blumenthal, A. et al. (2006) Blood 108:965.
- He, X. et al. (1997) Science 275:1652.
- Caricasole, A. et al. (2003) J. Biol. Chem 278:37024.
- Zhang, J. et al. (2008) Invest. Ophthalmol. Vis. Sci. 49:5561.
- Sahores, M. et al. (2010) Development 137:2215.
- Slater, P.G. et al. (2013) PLoS One 8:e78892.
Alternate Names
Frizzled5, Frz-5, FZ-5, FZD5
Gene Symbol
FZD5
UniProt
Additional Frizzled-5 Products
Product Documents for Recombinant Human Frizzled-5 Fc Chimera (CHO-expressed), CF
Product Specific Notices for Recombinant Human Frizzled-5 Fc Chimera (CHO-expressed), CF
For research use only
Loading...
Loading...
Loading...